加载中
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
常规交易时段
US$23.175
−US$0.305 · -1.30%
盘中时间采用ET。市场数据可能有所延迟。
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
日内区间
当前US$23.175
52周区间
当前US$23.175
盘中时间采用ET。市场数据可能有所延迟。
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
日内区间
当前US$23.175
52周区间
当前US$23.175
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$27.50
上涨空间 18.66%价格历史记录不可用
最高：US$29.00平均的：US$27.50最低：US$26.00报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2039.36万0.00%2.3万亿 USD0.03%US$378.46-0.67%
iShares Russell 2000 ETFIWM1710.44万0.02%785.63亿 USD0.19%US$277.04-0.24%
Vanguard Extended Market ETFVXF601.01万0.01%954亿 USD0.05%US$232.33-0.50%
iShares Russell 2000 Growth ETFIWO599.25万0.04%142.49亿 USD0.24%US$352.43-0.83%
Vanguard Russell 2000 ETFVTWO379.44万0.02%180亿 USD0.06%US$111.88-0.29%
Schwab U.S. Small-Cap ETFSCHA317.08万0.01%216.99亿 USD0.03%US$32.5499-0.18%
iShares U.S. Medical Devices ETFIHI295.36万0.08%35.04亿 USD0.37%US$50.965+0.03%
F/M Emerald Life Sciences Innovation ETFLFSC220.17万1.86%1.16亿 USD0.79%US$41.6495-0.45%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAiShares U.S. Medical Devices ETFIHIF/M Emerald Life Sciences Innovation ETFLFSCAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
